Key facts
- This page summarizes Howard Lazarus's Form 4 filing for Avalyn Pharma Inc. (AVLN).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 01 May 2026, 18:26.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
25% of the shares underlying this option vest and become exercisable on September 12, 2025, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.